Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CareTrust REIT ( (CTRE) ) has shared an update.
On August 12, 2025, CareTrust REIT, Inc. entered into an underwriting agreement with major financial institutions to sell 20,000,000 shares of its common stock at $32.00 per share, with an option for an additional 3,000,000 shares, which was fully exercised the next day. The issuance of these shares, completed on August 14, 2025, was part of a strategic move to enhance the company’s financial positioning and potentially expand its operations within the healthcare real estate sector.
The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.
Spark’s Take on CTRE Stock
According to Spark, TipRanks’ AI Analyst, CTRE is a Outperform.
CareTrust REIT’s strong financial performance and strategic growth initiatives are the most significant factors driving the stock score. Positive technical indicators and recent corporate events further support the outlook. However, a relatively high valuation and potential regulatory risks slightly temper the overall score.
To see Spark’s full report on CTRE stock, click here.
More about CareTrust REIT
CareTrust REIT, Inc. operates in the real estate investment trust (REIT) industry, focusing on the acquisition, ownership, and leasing of healthcare-related properties. The company primarily deals with skilled nursing, assisted living, and independent living facilities, catering to the healthcare sector’s real estate needs.
Average Trading Volume: 1,969,051
Technical Sentiment Signal: Buy
Current Market Cap: $6.61B
See more data about CTRE stock on TipRanks’ Stock Analysis page.